Amarna Therapeutics B.V.
Primary tabs
About your organization / profile
Amarna Therapeutics B.V. is a gene and immunotherapy company headquartered in Leiden The Netherlands. We have developed the Nimvec viral gene delivery vector platform that based on its unique non-immunogenic properties is ideally suited for developing safe and effective treatments for genetic disorders, inflammatory/degenerative/autoimmune diseases and allergies. With highly promising proof-of-principle results we are currently seeking for a Series A investment to conduct a clinical phase 1/2 study on our "first-in-class" Nimvec-based tolerization therapy for type 1 Diabetes Mellitus.
Network (0)
There are no organizations in the network.
Recent activities
Amarna Therapeutics B.V. is now a member of the EIC ACCESS+ community.
Amarna Therapeutics B.V. has published fundraising documents.
Peter de Haan has joined Amarna Therapeutics B.V..